Skip to main content
. 2014 Aug 29;124(16):2544–2553. doi: 10.1182/blood-2013-12-546309

Figure 1.

Figure 1

Median number of somatic mutations identified by whole-exome sequencing. Comparison of mutation load between primary and relapse DLBCL samples (A), or between tumors with and without mutations in MMR genes (B-C). MMR-mutated tumors presented a significantly higher median of mutations (**P < .01, Mann-Whitney U test) than nonmutated cases. (B) All mutations. (C) InDels.